Leeman Stephanie A
University of Washington Medical Center, EEG & Clinical Neurophysiology, Box 356115, 1959 NE Pacific Street, Seattle, Washington 98195, USA.
Am J Electroneurodiagnostic Technol. 2005 Sep;45(3):186-91.
Neurofibromatosis is a disease that occurs in both males and females of all races and ethnic groups. It is inherited as a dominant disorder but can also occur as a new mutation. Neurofibromatosis was formerly considered a single disorder with at least two variations. However, it is currently known to be two distinct entities, Neurofibromatosis Type I (NF I), which is caused by a defective gene localized to chromosome 17 and Neurofibromatosis Type II (NF II), which is caused by a defective gene localized to chromosome 22. NF II is the less common form, affecting 1 in 40,000 persons. The distinguishing clinical feature of NF II is the presence of bilateral vestibular schwannomas. This is a case of a 15-year-old boy who presented with a mild hearing loss in the left ear and a nine month history of prominent hearing loss in the right ear. Brain magnetic resonance imaging (MRI) showed bilateral enhancing lesions in the cerebellopontine angle which extend into the internal auditory canal, consistent with vestibular schwannoma. He has no family history of Neurofibromatosis.
神经纤维瘤病是一种在所有种族和族裔的男性和女性中均会出现的疾病。它作为一种显性疾病遗传,但也可能作为一种新的突变出现。神经纤维瘤病以前被认为是一种单一疾病,至少有两种变体。然而,目前已知它是两种不同的病症,即I型神经纤维瘤病(NF I),由定位于17号染色体的缺陷基因引起;以及II型神经纤维瘤病(NF II),由定位于22号染色体的缺陷基因引起。NF II是较不常见的形式,每40000人中就有1人受影响。NF II的显著临床特征是双侧前庭神经鞘瘤的存在。这是一名15岁男孩的病例,他左耳有轻度听力损失,右耳有9个月的明显听力损失病史。脑部磁共振成像(MRI)显示双侧桥小脑角有强化病变,延伸至内耳道,符合前庭神经鞘瘤表现。他没有神经纤维瘤病家族史。